Plasminogen Activator Inhibitor 1: Clinical Trials

2 trials of Plasminogen Activator Inhibitor 1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 terminated. 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Active not recruiting 1
Phase 11Terminated 1
Phase 21Terminated 1

Follow Plasminogen Activator Inhibitor 1: new trials by email Literature Review of Plasminogen Activator Inhibitor 1 trials Research Report on Plasminogen Activator Inhibitor 1

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Bioflavanoids on Vascular Wall Remodeling in Patients With Varicose Veins
"VenarusĀ®" (diosmin and hesperidin), Endovenous laser ablation (EVLA) with miniphlebectomy, Elastic compression - Varicose Veins of Lower Limb, Varix
Not applicableActive not recruitingRyazan State Medical University1002023-04-012025-07-23
Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19
TM5614, Placebo - Covid19
Phase 1 / Phase 2TerminatedNorthwestern University92021-01-082026-09-25

Conditions studied

COVID-19 (1)  ·  Varicose Veins (1)  ·  Vascular Diseases (1)

Sponsors

Northwestern University (1)  ·  Ryazan State Medical University (1)

Countries

Russia (1)  ·  United States (1)

Top investigators

Igor Suchkov (1)  ·  Sanjiv Shah, MD (1)